Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Clinical trial NCT01031953 · TERMINATED

Trial details

NCT number: NCT01031953
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breakthrough Nausea and Vomiting Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2008-08-01
Primary completion: 2013-02-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.